期刊文献+
共找到202篇文章
< 1 2 11 >
每页显示 20 50 100
Endometrial carcinoma with cervical stromal invasion:Three case reports
1
作者 Ming-Ming Liu Yu-Ting Liang Er-Hu Jin 《World Journal of Clinical Cases》 SCIE 2024年第24期5583-5588,共6页
BACKGROUND Endometrial cancer is a kind of well-known tumors of female genitourinary system.Cervical stromal invasion is an adverse factor for poor prognosis of endometrial cancer.There is still controversy regarding ... BACKGROUND Endometrial cancer is a kind of well-known tumors of female genitourinary system.Cervical stromal invasion is an adverse factor for poor prognosis of endometrial cancer.There is still controversy regarding the use of magnetic resonance imaging(MRI)in the diagnosis of cervical stromal invasion of endometrial cancer.The diagnosis of cervical stromal invasion varies significantly between different observers and institutions.We present a limited case series of the particular pattern of endometrial cancer,which infiltrates the cervical stroma and is often overlooked.CASE SUMMARY We present three cases of endometrial carcinoma with cervical stromal invasion with cancer-free uterine cavity.One patient,a reproductive-aged woman,exhibited irregular menstruation and was diagnosed with endometrial polyps by hysteroscopy and segmental curettage.A MRI scan revealed polypoid nodules within the internal cervical orifice.The other two cases were postmenopausal women who presented with abnormal vaginal bleeding.Hysteroscopy and segmental curettage suggested atypical hyperplasia of the endometrium.MRI scans did not detect any malignant signs in the endometrium.In one case,a nonthickened endometrium was observed,while in another,hyperplasia of the endometrium was seen.Notably,none of these patients had malignant tumors identified in the uterine cavity via MRI scans.However,postoperative pathological results following hysterectomy consistently indicated cervical stromal invasion.CONCLUSION Cervical stromal invasion is easily missed if no cancer is found in the uterine body on MRI.Immunohistochemistry of endoscopic curettage specimens should be conducted to avoid underestimation of the disease. 展开更多
关键词 endometrial carcinoma Cervical stromal invasion atypical hyperplasia of the endometrium Magnetic resonance imaging Case report
下载PDF
Atypical endometrial hyperplasia in a 35-year-old woman:A case report and literature review
2
作者 Xiang Wu Jun Luo +5 位作者 Fei Wu Neng Li Ai-Qiong Tang Ang Li Xiao-Ling Tang Min Chen 《World Journal of Clinical Cases》 SCIE 2021年第31期9629-9634,共6页
BACKGROUND Atypical endometrial hyperplasia(AEH)is a common precancerous lesion of endometrial carcinoma(EC).The risk factors for AEH and EC directly or indirectly related to estrogen exposure include early menarche,n... BACKGROUND Atypical endometrial hyperplasia(AEH)is a common precancerous lesion of endometrial carcinoma(EC).The risk factors for AEH and EC directly or indirectly related to estrogen exposure include early menarche,nulliparity,polycystic ovarian syndrome,diabetes,and obesity.Both AEH and EC rarely occur in young patients(<40-years-old),who may desire to maintain their fertility.Evaluating the cancer risk of AEH patients is helpful for the determination of therapeutic plans.CASE SUMMARY We report a rare case of AEH in a 35-year-old woman who presented to the Hunan Provincial Maternal and Child Health Care Hospital with a large mass in the uterus.She married at 20-years-old,and had been married for more than 15 years to date.Several characteristics of this patient were observed,including nulliparity,limited sexual activity(intercourse 1-2 times a year)in recent years,and irregular vaginal bleeding for 2 years.Gynecological examination revealed an enlarged uterus,similar to the uterus size in the fourth month of pregnancy,and the uterine wall was relatively hard.Curettage was performed based on transvaginal sonography and magnetic resonance imaging results.Findings from the pathological examination were typical for AEH.The patient was cured after treatment with the standard therapy of high-dose progesterone.CONCLUSION In patients with intrauterine lumps that may be malignant,a pathological report should be obtained. 展开更多
关键词 atypical endometrial hyperplasia Abnormal uterine bleeding INFERTILITY Large mass in the uterus Case report
下载PDF
Atypical Polypoid Adenomyoma (APAM) of the Uterine: Relationship with Endometrial Cancer 被引量:3
3
作者 Iori Kisu Kouji Banno +9 位作者 Megumi Yanokura Yusuke Kobayashi Arisa Ueki Asuka Ono Kennta Masuda Wataru Yamagami Hiroyuki Nomura Akira Hirasawa Nobuyuki Susumu Daisuke Aoki 《Journal of Cancer Therapy》 2011年第4期458-462,共5页
Atypical polypoid adenomyoma (APAM) is a rare polypoid tumor that generally occurs in women of reproductive age who have abnormal genital bleeding. The tumor was reported as a new disease concept by Mazur in 1981. Pat... Atypical polypoid adenomyoma (APAM) is a rare polypoid tumor that generally occurs in women of reproductive age who have abnormal genital bleeding. The tumor was reported as a new disease concept by Mazur in 1981. Pathologically, APAM consist of irregularly proliferated endometrial gland cells and interlacing bundles of smooth muscle cells within the stroma, and have a similar form to adenocarcinoma, adenofibroma, adenosarcoma, and carcinosarcoma. Therefore, differential diagnosis is required in many cases. APAM is pathologically classified as a benign lesion and clinically has a comparatively favorable outcome. However, treatment and follow-up observation should be performed carefully because recurrence and residual lesions occur in many patients after conservative treatment. Concomitant development of endometrial adenocarcinoma also occurs in many cases and it is difficult to differentiate this disease from APAM. Thus, diagnosis of APAM should be made carefully, particularly since the number of cases of endometrial adenocarcinoma has increased in recent years. Furthermore, APAM tends to develop during a woman’s reproductive years, and fertility sparing treatment should be considered. Here, we review the clinicopathological characteristics of APAM, including the difficulty of diagnosis as a benign or malignant uterine tumor, and we examine the relationship between APAM and endometrial cancer. 展开更多
关键词 atypical POLYPOID ADENOMYOMA endometrial Adenocarcinoma atypical endometrial hyperplasia Transcervical RESECTOSCOPE Fertility Sparing
下载PDF
Is the Use of Frozen Section Indispensable in the Surgical Treatment of Endometrial Hyperplasia?
4
作者 Ceyhun Numanoglu Dilek Marangoz Chapman +4 位作者 Aysun Fendal Tunca Aysu Akca Agahan Han Volkan Ulker Ozgur Akbayir 《Open Journal of Obstetrics and Gynecology》 2015年第4期219-225,共7页
Objective: To evaluate the reliability and accuracy of frozen section (FS) compared with final pathology and to determine whether they should be obligatory in every patient with atypical endometrial hyperplasia (AEH).... Objective: To evaluate the reliability and accuracy of frozen section (FS) compared with final pathology and to determine whether they should be obligatory in every patient with atypical endometrial hyperplasia (AEH). Methods: We retrospectively assessed the medical records of 192 patients whose endometrial biopsy results were endometrial hyperplasia and underwent hysterectomy at our center. Results: Twenty-two (11.4%) of the 192 patients in our study had concurrent endometrial carcinoma (EC). Of these, 21 (95.5%) were EC and 1 (4.5%) was non-endome- trioid. Of the 140 patients with AEH, 20 (14.3%) had concurrent EC. Overall, 157 patients had FS. Two (1%) patients’ EC was higher than grade 1B and needed lymphadenectomy. The positive and negative predictive value, specifity and sensitivity of FS were found to be 77.8%, 95.7%, 97% and 70%, respectively. Conclusion: Patients who have AEH without high-risk comorbidities do not have to be referred to oncology centers and can undergo hysterectomy in community hospitals without FS. 展开更多
关键词 endometrial hyperplasia Coexisting endometrial Cancer atypical endometrial hyperplasia FROZEN SECTION HYSTERECTOMY
下载PDF
子宫内膜不典型增生/早期子宫内膜癌患者保留生育功能治疗后IVF-ET妊娠结局及复发因素分析
5
作者 陶陶 邓成艳 +6 位作者 王含必 甄璟然 孙正怡 郁琦 潘凌亚 曹冬焱 周远征 《生殖医学杂志》 CAS 2024年第3期283-290,共8页
目的分析子宫内膜不典型增生/早期子宫内膜癌(AH/EEC)患者保留生育功能治疗后接受体外受精-胚胎移植(IVF-ET)治疗的临床特点和预后,分析影响助孕妊娠结局和疾病复发的主要因素。方法回顾性分析2012年2月至2022年2月在北京协和医院接受AH... 目的分析子宫内膜不典型增生/早期子宫内膜癌(AH/EEC)患者保留生育功能治疗后接受体外受精-胚胎移植(IVF-ET)治疗的临床特点和预后,分析影响助孕妊娠结局和疾病复发的主要因素。方法回顾性分析2012年2月至2022年2月在北京协和医院接受AH/EEC生育保留治疗后进行IVF-ET治疗的78例患者的临床资料。总结分析纳入患者的临床特征、IVF-ET相关指标、妊娠结局和复发情况,以单因素和多因素分析临床妊娠率、活产率以及疾病复发的影响因素。结果78例患者中51例(65.38%)为AH患者,27例(34.62%)为EEC患者;开始IVF-ET周期的平均年龄为(34.17±3.70)岁。共有74例患者至少接受了1次移植,每移植周期的临床妊娠率和活产率分别为36.31%(65/179)和18.99%(34/179),累积妊娠率为72.97%(54/74)。多因素分析提示子宫内膜病变初次发病年龄是活产率的独立影响因素[OR=0.8794,95%CI(0.785,0.983),P=0.02]。纳入患者IVF-ET期间子宫内膜病变的总复发率为6.41%(5/78),多因素分析提示子宫内膜病变的病理类型和IVF-ET前复发史是疾病复发的危险因素(P<0.05)。结论AH/EEC患者保留生育功能治疗后的辅助生殖结局相对满意,在肿瘤治疗过程中,进行病变评估时应尽量保护内膜,减少损伤;在肿瘤治疗结束后,应尽快进行助孕治疗,以最大程度降低复发率。 展开更多
关键词 子宫内膜不典型增生 早期子宫内膜癌 保留生育功能治疗 体外受精-胚胎移植
下载PDF
早期子宫内膜癌及子宫内膜非典型增生保守治疗回顾性研究
6
作者 王圆圆 来天娇 +2 位作者 王家祎 严淑萍 郭瑞霞 《河南大学学报(医学版)》 CAS 2024年第3期214-219,共6页
目的:回顾性分析早期子宫内膜癌及子宫内膜非典型增生患者应用高效孕激素为基础的保留生育功能治疗后的疗效、复发率及妊娠情况。方法:选取2010年1月至2022年12月就诊于郑州某医院和新乡某医院进行早期子宫内膜癌(endometrial carcinoma... 目的:回顾性分析早期子宫内膜癌及子宫内膜非典型增生患者应用高效孕激素为基础的保留生育功能治疗后的疗效、复发率及妊娠情况。方法:选取2010年1月至2022年12月就诊于郑州某医院和新乡某医院进行早期子宫内膜癌(endometrial carcinoma, EC)及子宫内膜非典型增生(atypical endometrial hyperplasia, AEH)保育治疗的患者为研究对象,分析EC组和AEH组完成治疗后的完全缓解率(complete response, CR)、部分缓解率(partial response, PR)、复发率(recurrence rate, RR)及妊娠结局。结果:共96例患者纳入分析,其中EC组33例,AEH组63例。治疗9个月评估时,EC组CR率为78.8%(26/33),AEH组CR率为82.5%(52/63),两组间差异无统计学意义(P>0.05),两组完全缓解率达83.3%。EC和AEH组获得病理起效的平均时间分别为(3.54±1.76)个月、(3.18±1.50)个月,获得完全缓解的平均时间分别为(5.71±2.40)个月、(5.39±2.65)个月。AEH组起效时间及完全缓解时间均短于EC组,但两组间无显著性差异(P>0.05)。EC组复发率为30.7%,平均复发时间为(21.11±11.00)个月;AEH组复发率为26.5%,平均复发时间为(33.23±14.96)个月。两组总体复发率为26.9%。平均复发时间为(28.61±14.59)个月,两组复发率比较无统计学意义(P>0.05)。两组共有58例(74.3%)患者要求治疗后立即妊娠,最终成功妊娠率为39.6%,总的妊娠次数25次,足月妊娠产下活产儿18个,活产率为78.2%。结论:EC和AEH采用高效孕激素为基础的保育治疗可以达到很高的缓解率及妊娠率,可以为不孕患者争取妊娠时间,但复发率高,妊娠完成后建议尽早手术治疗。 展开更多
关键词 子宫内膜癌 子宫内膜非典型增生 完全缓解 部分缓解
下载PDF
分子分型预测子宫内膜癌及子宫内膜非典型增生患者保留生育功能治疗后的预后及生育结局
7
作者 王家祎 郭瑞霞 +3 位作者 姜国忠 严淑萍 金玉茜 付翰林 《现代妇产科进展》 2024年第9期648-655,661,共9页
目的:分析不同分子分型对接受保留生育功能治疗的子宫内膜癌(EC)及子宫内膜非典型增生(AEH)患者肿瘤预后及妊娠结局的影响。方法:回顾性收集2012年1月至2021年12月在郑州大学第一附属医院接受保留生育功能治疗的95例EC或AEH患者的临床... 目的:分析不同分子分型对接受保留生育功能治疗的子宫内膜癌(EC)及子宫内膜非典型增生(AEH)患者肿瘤预后及妊娠结局的影响。方法:回顾性收集2012年1月至2021年12月在郑州大学第一附属医院接受保留生育功能治疗的95例EC或AEH患者的临床资料。采用Sanger测序和免疫组化染色(IHC)方法,根据EC前瞻性分子危险分类法(ProMisE)将患者分为4组:POLE核酸外切酶域突变型(POLE EDM)、错配修复缺陷型(MMRd)、p53突变型(p53abn)和p53野生型(p53wt)。比较分析不同分子分型患者的一般情况、肿瘤预后及生育结局。结果:对95例患者首次就诊时的病理组织进行检测,其中POLE EDM型2例、MMRd型25例、p53abn型5例、p53wt型63例。MMRd型和p53wt型的一般情况、肿瘤预后及生育结局比较,差异无统计学意义(P>0.05)。根据病变严重程度进行亚组分析,EC亚组中MMRd型和p53wt型患者的复发率分别为66.7%和16.7%(P=0.019),AEH亚组中MMRd和p53wt组患者的妊娠率分别为18.2%和71.4%(P=0.006),差异均有统计学意义。根据不同的治疗方法,接受口服高效孕激素治疗的MMRd型和p53wt型患者在9个月时的完全缓解率分别为50.0%和82.9%,差异有统计学意义(P=0.046)。结论:分子分型对早期EC及AEH患者接受保留生育功能治疗前进行评估是可行的。MMRd型和p53wt型在接受保留生育治疗后均表现出良好的预后和生育结果,其中p53wt型可能获益更多。 展开更多
关键词 子宫内膜癌 子宫内膜非典型增生 分子分型 保育治疗 预后 生育结局
下载PDF
罕见重度肥胖少女子宫内膜不典型增生1例并文献复习
8
作者 尚丹丹 李丽 +2 位作者 曹璋 张丽丽 周超 《国际医药卫生导报》 2024年第5期853-856,共4页
子宫内膜不典型增生是常见子宫内膜疾病,也是子宫内膜癌的癌前病变,近年来有年轻化趋势。本文报道1例罕见16岁重度肥胖少女,以阴道大量流血收入滨州医学院附属医院,行宫腔镜手术后病理结果提示子宫内膜不典型增生。
关键词 子宫内膜不典型增生 少女 子宫内膜癌 重度肥胖 文献复习
下载PDF
临床特征在术前诊断子宫腺肌病合并子宫内膜癌中的作用
9
作者 杨超逸 谭爱丽 《安徽医科大学学报》 CAS 北大核心 2024年第5期885-889,共5页
目的分析子宫腺肌病(AM)与合并子宫内膜癌(EC)患者的临床特征及在术前诊断中的作用。方法收集最终经病理检查确定为AM合并EC或子宫内膜非典型增生(EAH)以及同期有异常子宫出血(AUB)的AM患者共142例,根据是否合并EC或EAH分为AM合并EC或EA... 目的分析子宫腺肌病(AM)与合并子宫内膜癌(EC)患者的临床特征及在术前诊断中的作用。方法收集最终经病理检查确定为AM合并EC或子宫内膜非典型增生(EAH)以及同期有异常子宫出血(AUB)的AM患者共142例,根据是否合并EC或EAH分为AM合并EC或EAH组(71例)和对照组(71例),对患者的临床资料进行回顾性分析,探讨AM合并EC患者的临床特征及治疗策略的制定。结果单因素分析结果显示AM合并EC或EAH组患者的年龄、CA125及CA125升高的比例、子宫体积、合并高血压、超声存在内膜异常声像的比例均显著高于对照组,痛经的比例显著低于对照组,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,超声的内膜增厚、内膜回声不均、内膜增厚合并回声不均是AM合并EC或EAH的独立危险因素。结论临床上应对超声具有内膜增厚或回声不均声像的AM患者先行宫腔镜诊刮取得病理结果后再进一步制定手术方案,以达到早期诊治EC的目的。 展开更多
关键词 子宫腺肌病 子宫内膜癌 子宫内膜不典型增生 异常子宫出血 危险因素 术前诊断
下载PDF
子宫内膜非典型增生的临床检验指标分析
10
作者 任健 郝焰 +1 位作者 卢丹 刘勇 《中国医疗设备》 2023年第7期139-144,共6页
目的 分析子宫内膜非典型增生(Endometrial Atypical Hyperplasia,EAH)的临床检验指标,寻找危险因素及诊断预测指标,为疾病的预防及筛查诊断提供新思路。方法 收集2020年6月至2021年12月于首都医科大学附属北京妇产医院妇科行宫腔镜治疗... 目的 分析子宫内膜非典型增生(Endometrial Atypical Hyperplasia,EAH)的临床检验指标,寻找危险因素及诊断预测指标,为疾病的预防及筛查诊断提供新思路。方法 收集2020年6月至2021年12月于首都医科大学附属北京妇产医院妇科行宫腔镜治疗的211例患者的临床资料,EAH患者为研究组(n=107),宫腔粘连患者为对照组(n=104)。回顾性分析两组患者的妊娠次数、初潮年龄、体质指数(Body Mass Index,BMI)、实验室检验指标及子宫内膜厚度、子宫体积等项目,并探寻疾病相关危险因素及有效诊断预测指标。结果 研究组BMI、血小板计数、低密度脂蛋白胆固醇、子宫内膜厚度及子宫体积均高于对照组,差异有统计学意义(P<0.001);研究组甘油三酯高于对照组,差异有统计学意义(P<0.01);研究组国际标准比值(International Normalized Ratio,INR)及高密度脂蛋白胆固醇(High Density Lipoprotein Cholesterol,HDL-C)低于对照组,差异有统计学意义(P<0.001);研究组妊娠次数低于对照组,差异有统计学意义(P<0.05)。HDL-C、INR、子宫内膜厚度及子宫体积为EAH的独立危险因素(P<0.05),其中子宫内膜厚度危险性最大(OR=5.984)。子宫体积预测EAH的受试者工作特征曲线下面积为0.947(95%CI:0.912~0.982),优于子宫内膜厚度。结论 HDL-C、INR、子宫内膜厚度及子宫体积为EAH的独立危险因素,其中子宫内膜厚度危险性最大,而子宫体积对疾病预测有较好的临床意义。应在工作中提高对以上检验检查指标的重视,并对临床诊断截断值的确定进行深入研究,以利于疾病的快速筛查及预防。 展开更多
关键词 子宫内膜非典型增生 高密度脂蛋白胆固醇 国际标准比值 子宫体积 子宫内膜厚度
下载PDF
孕激素联合宫腔镜治疗早期子宫内膜癌及不典型增生患者的效果及复发情况分析
11
作者 岳红 李静 《实用癌症杂志》 2023年第11期1903-1906,共4页
目的 探讨孕激素联合宫腔镜治疗早期子宫内膜癌(EC)及不典型增生(EAH)患者的效果及复发情况。方法 选取保留生育功能的32例早期EC和58例EAH患者作为研究对象,均使用孕激素联合宫腔镜治疗,评估临床效果。同时收集所有患者的年龄、BMI指... 目的 探讨孕激素联合宫腔镜治疗早期子宫内膜癌(EC)及不典型增生(EAH)患者的效果及复发情况。方法 选取保留生育功能的32例早期EC和58例EAH患者作为研究对象,均使用孕激素联合宫腔镜治疗,评估临床效果。同时收集所有患者的年龄、BMI指数、不孕史、病灶直径、病灶形态等临床资料,分析影响治疗后复发的相关因素。结果 90例EC及EAH患者经治疗后均达到完全缓解,其中27例出现治疗后复发,63例未出现复发,复发率为30.00%(27/90)。复发患者中有6例患者开展了分期手术,14例患者再次进行保守治疗后达缓解,7例患者仍在治疗中。BMI指数、病灶直径、使用促排卵药物是影响EC及EAH患者保留生育功能治疗后复发的单因素(P<0.05);logistic回归分析显示,BMI指数>25 kg/m^(2)、病灶直径>2 cm、使用促排卵药物是EC及EAH患者保留生育功能治疗后复发的危险因素(P<0.05)。结论 EC及EAH患者保留生育功能治疗后复发影响因素主要为BMI指数、病灶直径和使用促排卵药物,临床应加强对危险因素的监测,并针对性采取预防措施,降低复发率。 展开更多
关键词 子宫内膜癌 不典型增生 孕激素 宫腔镜 复发
下载PDF
早期子宫内膜癌及子宫内膜非典型增生患者经保留生育功能治疗后的结局分析
12
作者 林婷婷 安健 +1 位作者 许雅云 陈琼华 《中国医药指南》 2023年第29期1-5,共5页
目的 分析早期子宫内膜癌(EC)及子宫内膜非典型增生(AEH)患者经保留生育功能治疗后的结局。方法 选取2012年7月至2022年10月首诊厦门大学附属第一医院患者46例EC和AEH患者,其中EC组19例和AEH组27例,统计分析其临床资料。结果 46例患者... 目的 分析早期子宫内膜癌(EC)及子宫内膜非典型增生(AEH)患者经保留生育功能治疗后的结局。方法 选取2012年7月至2022年10月首诊厦门大学附属第一医院患者46例EC和AEH患者,其中EC组19例和AEH组27例,统计分析其临床资料。结果 46例患者治疗后完全缓解(CR)率76.1%(35/46),其中EC组CR率73.7%(14/19),AEH组CR率77.8%(21/27)。分析显示BMI≥25.0 kg/m^(2)的患者、合并糖尿病/胰岛素抵抗的患者治疗后CR率更低,OR值分别为5.344(95%CI:1.006~28.395)、0.106(95%CI:0.016~0.697)。而年龄、是否癌变、合并多囊卵巢综合征(PCOS)、合并子宫内膜异位症均与CR率无关。所有患者经治疗后总妊娠率53.6%(15/28),EC组妊娠率57.1%(8/14),AEH组妊娠率50.0%(7/14);治疗后总活产率39.3%(11/28),EC组活产率35.7%(5/14),AEH组42.9%(6/14)。BMI值是否<25.0 kg/m^(2),妊娠组与非妊娠组比较差异有统计学意义(P <0.05),高BMI者发生妊娠失败风险的OR值6.188(95%CI:1.198~31.967)。而年龄、达CR时间、是否癌变,及是否合并PCOS、合并糖尿病/胰岛素抵抗、合并子宫内膜异位症,差异无统计学意义(P> 0.05)。结论 EC、AEH患者经过保留生育功能治疗能获得较高的CR率和一定的妊娠率,BMI≥25 kg/m^(2)或合并有糖尿病/胰岛素抵抗的患者治疗后CR率更低。BMI <25.0 kg/m^(2)的患者治疗达CR后更容易妊娠。 展开更多
关键词 早期子宫内膜癌 子宫内膜非典型增生 高效孕激素 保留生育功能 妊娠结局
下载PDF
绝经后子宫内膜增厚及宫腔占位用于预测子宫内膜癌的阈值探讨 被引量:1
13
作者 李勤妹 李金枝 《实用妇产科杂志》 CAS CSCD 北大核心 2023年第1期56-60,共5页
目的:探讨绝经后子宫内膜厚度及宫腔内病灶大小用于预测子宫内膜不典型增生(AH)及子宫内膜癌(EC)最佳阈值和AH及EC的高危因素。方法:回顾性分析2016年1月1日至2020年12月31日在复旦大学附属金山医院就诊,因各种原因行宫腔镜诊刮及子宫... 目的:探讨绝经后子宫内膜厚度及宫腔内病灶大小用于预测子宫内膜不典型增生(AH)及子宫内膜癌(EC)最佳阈值和AH及EC的高危因素。方法:回顾性分析2016年1月1日至2020年12月31日在复旦大学附属金山医院就诊,因各种原因行宫腔镜诊刮及子宫内膜病灶切除的绝经后女性共533例。分析其临床病理资料,二项Logistic回归分析AH及EC的危险因素。按有无绝经后出血(PMB)分为两个亚组,分别行受试者工作特征(ROC)曲线分析子宫内膜厚度和病灶大小的最佳阈值。结果:(1)AH及EC的发生率4.32%,PMB患者和无PMB患者AH及EC的发生率分别为8.18%和2.67%。(2)二项Logistic回归分析显示,子宫内膜增厚、病灶较大、内膜边界不清、内膜血流信号丰富是AH及EC的独立危险因素(OR>1,P<0.05)。(3)ROC曲线分析显示:子宫内膜厚度最佳阈值,非PMB患者为9.8 mm,AUC为0.718,敏感度66.7%,特异度78.7%;PMB患者为7.0 mm,AUC为0.832,敏感度85.7%,特异度76.0%。病灶大小最佳阈值,非PMB患者为12.7 mm,AUC为0.826,敏感度83.3%,特异度77.7%;PMB患者为11.3 mm,AUC为0.787,敏感度100.0%,特异度65.9%。结论:以子宫内膜厚度和宫腔内病灶大小来预测子宫内膜恶变风险是可行的,但应根据PMB状态采取不同的阈值。 展开更多
关键词 子宫内膜癌 不典型增生 绝经后出血 子宫内膜厚度 宫腔占位
下载PDF
屈螺酮炔雌醇片与左炔诺孕酮宫内节育系统联合治疗子宫内膜增生不伴非典型增生的效果观察 被引量:2
14
作者 张妍 《中国现代药物应用》 2023年第9期114-117,共4页
目的探究屈螺酮炔雌醇片与左炔诺孕酮宫内节育系统联合治疗子宫内膜增生不伴非典型增生的效果。方法100例子宫内膜增生不伴非典型增生患者作为研究对象,按照电脑随机法分为观察组和对照组,每组50例。对照组采用左炔诺孕酮宫内节育系统治... 目的探究屈螺酮炔雌醇片与左炔诺孕酮宫内节育系统联合治疗子宫内膜增生不伴非典型增生的效果。方法100例子宫内膜增生不伴非典型增生患者作为研究对象,按照电脑随机法分为观察组和对照组,每组50例。对照组采用左炔诺孕酮宫内节育系统治疗,观察组在对照组基础上加用屈螺酮炔雌醇片治疗。对比两组治疗前后子宫内膜厚度、月经周期以及月经期,不良反应发生情况,治疗前后卵巢储备功能指标[窦卵泡计数(AFC)、卵泡刺激素(FSH)、促黄体素(LH)、雌二醇(E_(2))]。结果治疗前,两组患者的子宫内膜厚度、月经期、月经周期对比差异无统计学意义(P>0.05);治疗后,两组患者的子宫内膜厚度小于本组治疗前,月经期、月经周期均短于本组治疗前,观察组子宫内膜厚度(5.25±1.02)mm小于对照组的(7.52±1.74)mm,月经期(4.51±1.01)d、月经周期(28.52±1.41)d均短于对照组的(7.52±1.52)、(30.85±1.47)d,差异具有统计学意义(P<0.05)。观察组患者的不良反应发生率2.00%显著低于对照组的20.00,差异具有统计学意义(P<0.05)。两组治疗前后组间AFC、FSH、LH、E_(2)水平对比差异均无统计学意义(P>0.05)。结论子宫内膜增生不伴非典型增生患者采用屈螺酮炔雌醇片与左炔诺孕酮宫内节育系统联合治疗的效果显著,且安全性高,值得研究和推广。 展开更多
关键词 子宫内膜增生不伴非典型增生 屈螺酮炔雌醇片 左炔诺孕酮宫内节育系统
下载PDF
Microscale endometrial sampling biopsy in detecting endometrial cancer and atypical hyperplasia in a population of 1551 women:a comparative study with hysteroscopic endometrial biopsy 被引量:7
15
作者 Guo Zhang Yue Wang +4 位作者 Xu-Dong Liang Rong Zhou Xiu-Li Sun Jian-Liu Wang Li-Hui Wei 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第2期193-199,共7页
Background:Endometrial cancer is one of the most common malignancies of the reproductive system.Effective and cost-effective screening method for populations at high risk is not available.This study aimed to investiga... Background:Endometrial cancer is one of the most common malignancies of the reproductive system.Effective and cost-effective screening method for populations at high risk is not available.This study aimed to investigate specimen adequacy and the influencing factors in microscale endometrial sampling biopsy and to evaluate the diagnostic accuracy and medical cost of biopsy in endometrial cancer and atypical hyperplasia screenings in comparison with hysteroscopic endometrial biopsy.Methods:A total of 1551 patients at high risk for endometrial lesions who required hysteroscopic endometrial biopsy from November 2017 to August 2018 were included.Microscale endometrial sampling biopsy was performed,followed by hysteroscopic endometrial biopsy.We evaluated the specimen adequacy and influencing factors of microscale endometrial sampling.Diagnostic consistency between microscale endometrial sampling biopsy and hysteroscopic endometrial biopsy was evaluated.The sensitivity,specificity,positive predictive value,and negative predictive value of microscale endometrial sampling biopsy in screening for endometrial cancer and atypical hyperplasia were analyzed,and the medical costs of the two procedures were compared.Results:The specimen adequacy was 81.2%.Patient age,menopausal status,endometrial thickness,and endometrial lesion type were correlated with specimen adequacy.There was good consistency in distinguishing benign and malignant endometrial diseases between microscale endometrial sampling biopsy and hysteroscopic biopsy(kappa 0.950,95%CI 0.925-0.975).The sensitivity,specificity,positive predictive value,and negative predictive value of microscale endometrial sampling biopsy were 91.7%,100.0%,100.0%,and 99.3%for endometrial cancer screening,respectively,and 82.0%,100.0%,100.0%,and 99.4%for atypical hyperplasia screening.The medical cost of endometrial sampling biopsy was only 22.1%of the cost of hysteroscopic biopsy.Conclusions:Microscale endometrial sampling biopsy is a minimally invasive alternative technique for obtaining adequate endometrial specimens for histopathological examination.It has the potential to be used in detecting endometrial cancer and atypical hyperplasia with high efficiency and low cost. 展开更多
关键词 endometrial atypical hyperplasia endometrial cancer Hysteroscopic endometrial biopsy Microscale endometrial sampling biopsy
原文传递
Expression of Survivin Gene among Human Normal Endometrium,Atypical Hyperplasia of Endometrium and Endometrial Carcinoma 被引量:4
16
作者 Jian-ying XU Shu-fang WANG +1 位作者 Zhong-yan WAN Wei-jie ZHU 《Journal of Reproduction and Contraception》 CAS 2010年第3期129-135,共7页
Objective To investigate the expression of survivin gene among human normal endometrium,atypical hyperplasia of endometrium,and endometrial carcinoma.Methods Tissue samples of human normal endometrium during prolifera... Objective To investigate the expression of survivin gene among human normal endometrium,atypical hyperplasia of endometrium,and endometrial carcinoma.Methods Tissue samples of human normal endometrium during proliferative phase (NE,n=20),atypical hyperplasia of endometrium (AHE,n=11),and endometrial carcinoma (EC,n=9) were collected.Besides,Paraffin embedded sections of NE (n=20),AHE (n=20),and EC (n=20) were used.The expression of survivin gene was determined by immunohistochemistry and the real-time reverse transcription polymerase chain reaction.Results Survivin immunostaining appeared in the cytoplasm of endometrial epithelial cells.Both survivin staining and mRNA had higher levels in AHE or EC than those in NE (P〈0.01).No difference was found on survivin staining and mRNA between AHE and EC (P〉0.05).Conclusion High expression of survivin gene in human endometrium is associated with the risk of atypical hyperplasia progressing to endometrial carcinoma.The high level of survivin expression is useful as a predictive indicator for endometrial carcinoma. 展开更多
关键词 SURVIVIN ENDOMETRIUM atypical hyperplasia of endometrium endometrial carcinoma
原文传递
Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia:A systematic review and meta-analysis 被引量:6
17
作者 Zerui Xiao Ziyi Song +2 位作者 Jianliu Wang Huixin Liu Qun Lu 《Gynecology and Obstetrics Clinical Medicine》 2021年第4期190-196,共7页
Objective:The objective of the study was to compare the effects of assisted reproductive technology(ART)and spontaneous pregnancy on pregnancy outcomes in women with endometrial carcinoma(EC)and atypical endometrial h... Objective:The objective of the study was to compare the effects of assisted reproductive technology(ART)and spontaneous pregnancy on pregnancy outcomes in women with endometrial carcinoma(EC)and atypical endometrial hyperplasia(AEH)following fertility-sparing treatments.Methods:Relevant studies published through July 2020 were identified from PubMed and Web of Science literature searches.The pregnancy outcomes of ART and spontaneous pregnancy were summarized and compared for women with complete remission of EC/AEH after fertility-sparing treatments.A subgroup analysis was performed based on whether patients had received in vitro fertilization and embryo transfer(IVF-ET)treatment.The complete remission and recurrence rates of EC/AEH following fertility-sparing treatments were estimated.The effect of pregnancy on recurrence rates of EC/AEH was also calculated.Results:Sixteen observational studies reporting pregnancy outcomes or recurrence with ART or spontaneous pregnancy for women with EC/AEH after fertility-sparing treatments were included.The complete remission rate of EC/AEH was 81.5%(95%CI,78%–85%).Compared with spontaneous pregnancy,the pregnancy rate of ART was significantly higher(66.8%vs.43.7%,OR=2.64,95%CI 1.71–4.05,P<0.00001,I^(2)=14%).Subgroup analysis showed that the pregnancy rate of IVF-ET was significantly higher than that of spontaneous pregnancy(62.7%vs.35.1%,OR=2.85,95%CI 1.44-5.63,P=0.003,I^(2)=29%).The live birth rate of ART was significantly higher than that of spontaneous pregnancy(75.3%vs.47.8%,OR=3.96,95%CI1.76-8.77,P=0.0009,I^(2)=45%).The recurrence rate of EC/AEH was 31%(95%CI 24%–39%).Clinical pregnancy could reduce the recurrence rate of EC/AEH,but there was no significant evidence of an association.Conclusions:ART,especially IVF-ET,could significantly improve pregnancy outcomes in women with EC/AEH receiving fertility-sparing treatments.Following complete remission,ART treatment might be a better option for women with EC/AEH than spontaneous pregnancy. 展开更多
关键词 endometrial carcinoma atypical endometrial hyperplasia Fertility sparing treatment Assisted reproductive technology In vitro fertilization and embryo transfer
原文传递
代谢综合征与子宫内膜非典型增生及子宫内膜癌的关系 被引量:1
18
作者 花晓玲 《实用妇科内分泌电子杂志》 2023年第23期16-18,共3页
目的分析代谢综合征与子宫内膜非典型增生(EAH)及子宫内膜癌(EC)的关系。方法选取13例子宫内膜非典型增生患者作为EAH组;另选取同期13例Ⅰ型子宫内膜癌患者作为Ⅰ型EC组,13例Ⅱ型子宫内膜癌患者作为Ⅱ型EC组,13例子宫切除后无子宫内膜... 目的分析代谢综合征与子宫内膜非典型增生(EAH)及子宫内膜癌(EC)的关系。方法选取13例子宫内膜非典型增生患者作为EAH组;另选取同期13例Ⅰ型子宫内膜癌患者作为Ⅰ型EC组,13例Ⅱ型子宫内膜癌患者作为Ⅱ型EC组,13例子宫切除后无子宫内膜病变者作为对照组。对比各组代谢指标。结果EAH组、Ⅰ型EC组、Ⅱ型EC组胰岛素抵抗率分别为61.54%、76.92%、84.62%,均高于对照组的7.69%(P<0.05)。EAH组、Ⅰ型EC组、Ⅱ型EC组的甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)指标高于对照组,高密度脂蛋白胆固醇(HDL-C)指标低于对照组(P<0.05)。Ⅰ型EC组、Ⅱ型EC组的纤维蛋白原(Fib)、纤维蛋白原降解产物(FDP)及D-二聚体(D-D)指标均高于EAH组、对照组(P<0.05)。结论胰岛素抵抗、血糖与血脂异常及凝血异常等代谢综合征在子宫内膜非典型增生及子宫内膜癌发病中起到了重要作用,在临床诊断中,可作为参考数据。 展开更多
关键词 代谢综合征 子宫内膜非典型增生 子宫内膜癌
下载PDF
Analysis on Reverse of Atypical Endometrial Hyperplasia by Drugs in Patients with Polycystic Ovary Syndrome 被引量:1
19
作者 Xiao-fang LOU Jin-fang LIN +1 位作者 Su-ping FANG Feng-ling WANG 《Journal of Reproduction and Contraception》 CAS 2013年第4期205-214,共10页
Objective To analyze the efficacy and safety of drugs on reverse of atypical endometrial hyperplasia in patients with polycystic ovary syndrome (PCOS). Methods Seventeen patients with PCOS complicated by atypical en... Objective To analyze the efficacy and safety of drugs on reverse of atypical endometrial hyperplasia in patients with polycystic ovary syndrome (PCOS). Methods Seventeen patients with PCOS complicated by atypical endometrial hyperplasia (9 patients who were treated with progestin but not reversed were considered as group A; 8 patients who were untreated were considered as group B) were retrospectively analyzed Both groups received oral glucose tolerance test (OGTT) and insulin release test, to check whether the patients had insulin resistance (IR) or hyperinsulinemia. The 17 patients were treated with oral contraceptives combined with metformin. Results After the 17 patients with PCOS complicated by IR and hyperinsulinemia received drug treatment for 3 -6 cycles, atypical endometrial hyperplasia was success- fully reversed Conclusion Oral contraceptives combined with metformin is a clinically practical and effective method for treatment of PCOS complicated by atypical insulin-resistant endometrial hyperplasia. 展开更多
关键词 polycystic ovary syndrome (PCOS) atypical endometrial hyperplasia insulinresistance (IR) oral contraceptives METFORMIN
原文传递
子宫内膜取样器获取两种标本筛查子宫内膜病变的临床应用研究
20
作者 王岚 唐忠庆 +1 位作者 张琳 陈清煦 《中国性科学》 2023年第11期88-92,共5页
目的评价子宫内膜取样器Pipelle获取两种子宫内膜标本筛查子宫内膜病变的临床应用价值。方法采用前瞻性、自身对照的方法,选取2020年12月至2022年3月梧州市工人医院收治的316例存在明确手术指征需进行宫腔镜检查和子宫内膜活检的患者作... 目的评价子宫内膜取样器Pipelle获取两种子宫内膜标本筛查子宫内膜病变的临床应用价值。方法采用前瞻性、自身对照的方法,选取2020年12月至2022年3月梧州市工人医院收治的316例存在明确手术指征需进行宫腔镜检查和子宫内膜活检的患者作为研究对象。采用子宫内膜取样器Pipelle获取子宫内膜标本,随后进行宫腔镜检查+常规诊刮术,Pipelle获取的子宫内膜标本同时进行液基细胞学制片及细胞模块石蜡包埋切片,以宫腔镜检查+常规刮宫术的组织学病理作为金标准进行比较。结果(1)常规诊刮术行组织石蜡切片满意率为97.78%(309/316),Pipelle获取标本行液基细胞学制片满意率为93.99%(297/316),行细胞模块石蜡包埋切片满意率为98.40%(311/316),两种石蜡切片的取材满意率均高于液基细胞学制片的取材满意率,差异具有统计学意义(P<0.05);两种石蜡切片的取材满意率比较,差异无统计学意义(P>0.05);Pipelle获取标本时无需麻醉和扩宫,患者无疼痛感。(2)Pipelle获取细胞模块组织病理学与液基细胞学筛查和诊断子宫内膜病变的灵敏度分别为68.75%、40.63%,特异度分别为99.27%、98.10%,阳性预测值分别为91.67%、72.22%,阴性预测值分别为96.45%、93.14%,符合率分别为96.08%、91.86%,Youden指数分别为0.61、0.39,Kappa值分别为0.76、0.47。结论Pipelle获取子宫内膜标本满意率高,标本进行细胞模块包埋石蜡切片组织病理学检查的准确性高于液基细胞学,Pipelle取样操作简便,无需麻醉,无疼痛感,适用于基层医院筛查子宫内膜病变。 展开更多
关键词 子宫内膜细胞取样器 Pipelle 液基细胞学 细胞模块 子宫内膜癌 子宫内膜非典型增生 子宫内膜病变
下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部